James Klinger, MD – SOX17 And RUNX1 as Novel Targets for Treatment of Pulmonary Hypertension Jan 16 James Klinger, MD – SOX17 And RUNX1 as Novel Targets for Treatment of Pulmonary Hypertension 3:00 pm - 4:00 pm
Jessica Plavicki, PhD – Identifying the development origin of late emerging proepicardial progenitor cells Jan 23 Jessica Plavicki, PhD – Identifying the development origin of late emerging proepicardial progenitor cells 3:00 pm - 4:00 pm
Reza Avaz, PhD – AI-Enabled Quantification of Cardiovascular Remodeling in Pulmonary Hypertension Jan 30 Reza Avaz, PhD – AI-Enabled Quantification of Cardiovascular Remodeling in Pulmonary Hypertension 3:00 pm - 4:00 pm
Yang Zhou, PhD – Immune Responses in Hermansky-Pudlak Syndrome-associated Lung Disease Feb 6 Yang Zhou, PhD – Immune Responses in Hermansky-Pudlak Syndrome-associated Lung Disease 3:00 pm - 4:00 pm
Arvin Soepriatna, PhD and Stephanie Roser, PhD Feb 13 Arvin Soepriatna, PhD and Stephanie Roser, PhD 3:00 pm - 4:00 pm
Navneet Singh, MD, ScM – The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension Feb 20 Navneet Singh, MD, ScM – The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension 3:00 pm - 4:00 pm